External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome

Intensive Care Medicine

Volumn 43, Issue 8, 2017, Pages 1123-1131

  Zhao, Zhiguo ^a   Wickersham, Nancy ^a   Kangelaris, Kirsten N ^b   May, Addison K ^a   Bernard, Gordon R ^a   Matthay, Michael A ^b   Calfee, Carolyn S ^b   Koyama, Tatsuki ^a   Ware, Lorraine B ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ARDS; Biomarker; Hospital mortality; Prediction; Validation

Indexed keywords

INTERLEUKIN 8; SIVELESTAT; SURFACTANT PROTEIN D; BIOLOGICAL MARKER;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGE; AGED; APACHE; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VALIDATION STUDY; ACUTE LUNG INJURY; ARTIFICIAL VENTILATION; BLOOD; MIDDLE AGED; MORTALITY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA;

ACUTE LUNG INJURY; ADULT; AGED; APACHE; BIOMARKERS; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; REPRODUCIBILITY OF RESULTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; ROC CURVE;

EID: 85020296441     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-017-4854-5     Document Type: Article

References (40)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693
2. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA, NHLBI ARDS Network (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611–620
3. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A, Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308
4. Takeda S, Ishizaka A, Fujino Y, Fukuoka T, Nagano O, Yamada Y, Takezawa J, Multicenter Clinical Trail Committee, Japan Society of Respiratory Care Medicine (2005) Time to change diagnostic criteria of ARDS: towards the disease entity-based subgrouping. Pulm Pharmacol Ther 18:115–119
5. Ospina-Tascon GA, Buchele GL, Vincent JL (2008) Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med 36:1311–1322
6. Prescott HC, Calfee CS, Thompson BT, Angus DC, Liu VX (2016) Toward smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design. Am J Respir Crit Care Med 194:147–155
7. Ware LB (2005) Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 33:S217–222
8. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand JA, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F, Alive Study Group (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51–61
9. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA (1995) Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 152:1818–1824
10. Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF, Brunet F (1998) Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 158:1076–1081
11. Nuckton TJ, Alonso JA, Kallet RH, Daniel BM, Pittet JF, Eisner MD, Matthay MA (2002) Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 346:1281–1286
12. Venet C, Guyomarc’h S, Pingat J, Michard C, Laporte S, Bertrand M, Gery P, Page D, Vermesch R, Bertrand JC, Zeni F (2003) Prognostic factors in acute respiratory distress syndrome: a retrospective multivariate analysis including prone positioning in management strategy. Intensive Care Med 29:1435–1441
13. Ware JH (2006) The limitations of risk factors as prognostic tools. N Engl J Med 355:2615–2617
14. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349
15. Sapru A, Calfee CS, Liu KD, Kangelaris K, Hansen H, Pawlikowska L, Ware LB, Alkhouli MF, Abbott J, Matthay MA, NHLBI ARDS Network (2015) Plasma soluble thrombomodulin levels are associated with mortality in the acute respiratory distress syndrome. Intensive Care Med 41:470–478
16. Geboers DG, de Beer FM, Tuip-de Boer AM, van der Poll T, Horn J, Cremer OL, Bonten MJ, Ong DS, Schultz MJ, Bos LD (2015) Plasma suPAR as a prognostic biological marker for ICU mortality in ARDS patients. Intensive Care Med 41:1281–1290
17. Laffey JG, Bellani G, Pham T, Fan E, Madotto F, Bajwa EK, Brochard L, Clarkson K, Esteban A, Gattinoni L, van Haren F, Heunks LM, Kurahashi K, Laake JH, Larsson A, McAuley DF, McNamee L, Nin N, Qiu H, Ranieri M, Rubenfeld GD, Thompson BT, Wrigge H, Slutsky AS, Pesenti A, LUNG SAFE Investigators and the ESICM Trials Group (2016) Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med 42:1865–1876
18. Cooke CR, Kahn JM, Caldwell E, Okamoto VN, Heckbert SR, Hudson LD, Rubenfeld GD (2008) Predictors of hospital mortality in a population-based cohort of patients with acute lung injury. Crit Care Med 36:1412–1420
19. Brown LM, Calfee CS, Matthay MA, Brower RG, Thompson BT, Checkley W, The National Institutes of Health Acute Respiratory Distress Syndrome Network (2011) A simple classification model for hospital mortality in patients with acute lung injury managed with lung protective ventilation. Crit Care Med 39:2645–2651
20. Cooke CR, Shah CV, Gallop R, Bellamy S, Ancukiewicz M, Eisner MD, Lanken PN, Localio AR, Christie JD, National Heart Lung Blood Institute Acute Respiratory Distress Syndrome Network (2009) A simple clinical predictive index for objective estimates of mortality in acute lung injury. Crit Care Med 37:1913–1920
21. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619–1636
22. Moreno RP, Metnitz PG, Metnitz B, Bauer P, Afonso de Carvalho S, Hoechtl A, SAPS 3 Investigators (2008) Modeling in-hospital patient survival during the first 28 days after intensive care unit admission: a prognostic model for clinical trials in general critically ill patients. J Crit Care 23:339–348
23. Villar J, Ambros A, Soler JA, Martinez D, Ferrando C, Solano R, Mosteiro F, Blanco J, Martin-Rodriguez C, Fernandez MM, Lopez J, Diaz-Dominguez FJ, Andaluz-Ojeda D, Merayo E, Perez-Mendez L, Fernandez RL, Kacmarek RM, Stratification Outcome of Acute Respiratory Distress Syndrome Network (2016) Age, PaO2/FIO2, and plateau pressure score: a proposal for a simple outcome score in patients with the acute respiratory distress syndrome. Crit Care Med 44:1361–1369
24. Bos LD, Schouten LR, Cremer OL, Ong DS, Schultz MJ, MARS Consortium (2016) External validation of the APPS, a new and simple outcome prediction score in patients with the acute respiratory distress syndrome. Ann Intensive Care 6:89
25. Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA, NHLBI ARDS Clinical Trials Network (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137:288–296
26. Ware LB, Zhao Z, Koyama T, Wickersham N, Kangelaris KN, Bernard GR, Matthay MA, Calfee CS (2015) Validation of a biomarker and clinical prediction model for mortality in ARDS in three patient cohorts. Am J Respir Crit Care Med 191:A6249
27. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT, The National Heart Lung Blood Institute Ards Clinical Trials Network (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336
28. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL, The National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575
29. Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, Bernard G, Strive Study Group (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32:1695–1702
30. O’Neal HR Jr, Koyama T, Koehler EA, Siew E, Curtis BR, Fremont RD, May AK, Bernard GR, Ware LB (2011) Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med 39:1343–1350
31. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824
32. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533
33. Schneider AG, Lipcsey M, Bailey M, Pilcher DV, Bellomo R (2013) Simple translational equations to compare illness severity scores in intensive care trials. J Crit Care 28(885):e881–888
34. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
35. Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y (2008) Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol 61:76–86
36. Sigurdsson MI, Sigvaldason K, Gunnarsson TS, Moller A, Sigurdsson GH (2013) Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand 57:37–45
37. Frank AJ, Thompson BT (2010) Pharmacological treatments for acute respiratory distress syndrome. Curr Opin Crit Care 16:62–68
38. Duggal A, Ganapathy A, Ratnapalan M, Adhikari NK (2015) Pharmacological treatments for acute respiratory distress syndrome: systematic review. Miner Anestesiol 81:567–588
39. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, Calfee CS, ARDS Network (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331–338
40. Taylor JM, Ankerst DP, Andridge RR (2008) Validation of biomarker-based risk prediction models. Clin Cancer Res 14:5977–5983